Human CD34+ blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade  Mario Arpinati, Carolina Terragna,

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Role of γ/δ T cells in a patient with CD4+ CD3– lymphocytosis, hypereosinophilia, and high levels of IgE  Ilan Bank, MDa,d, Avner Reshef, MDb, Miriam.
by JoAnn Castelli, Elaine K
Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
Cell-to-cell contact between activated CD4+ T lymphocytes and unprimed monocytes interferes with a TH1 response  Miriam Wittmann, MD, Mareike Alter, Tanja.
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1- Specific CD4+ T Cell Responses Showing Immunogenicity of all HLA-DPB1.
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Impaired negative regulation of homeostatically proliferating T cells
Volume 135, Issue 6, Pages (December 2008)
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment by.
by Norman Nausch, Ioanna E
Ex vivo induction of multiple myeloma–specific cytotoxic T lymphocytes
Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells by Wuding Zhou, Hetal Patel, Ke Li, Qi Peng, Marie-Bernadette.
Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants by Georg.
Ex Vivo Rapamycin Generates Th1/Tc1 or Th2/Tc2 Effector T Cells With Enhanced In Vivo Function and Differential Sensitivity to Post-transplant Rapamycin.
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells by Elke Scandella, Ying Men, Silke Gillessen,
Volume 31, Issue 2, Pages (August 2009)
Mature dendritic cells pulsed with freeze–thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4+ and CD8+ T lymphocyte.
HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients  Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,
Human CD4+CD25+ Cells in Combination with CD34+ Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity  Dolores Mahmud,
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
IL-13-Stimulated Human Keratinocytes Preferentially Attract CD4+CCR4+ T cells: Possible Role in Atopic Dermatitis  Rahul Purwar, Thomas Werfel, Miriam.
CD134-Allodepletion Allows Selective Elimination of Alloreactive Human T Cells without Loss of Virus-Specific and Leukemia-Specific Effectors  Xupeng.
Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Be Efficiently Expanded from Granulocyte Colony-Stimulating Factor–Mobilized Hemopoietic Progenitor.
Volume 141, Issue 3, Pages (September 2011)
Volume 132, Issue 7, Pages (June 2007)
Α-MSH-Stimulated Tolerogenic Dendritic Cells Induce Functional Regulatory T Cells and Ameliorate Ongoing Skin Inflammation  Matteo Auriemma, Thomas Brzoska,
Induction of chronic lymphocytic leukemia (CLL)–specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cells by Martin R. Müller,
Volume 18, Issue 5, Pages (May 2003)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses
Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates  George E. Georges, Marina.
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
Volume 7, Issue 4, Pages (October 2016)
T Cell–Mediated Rejection of Human CD34+ Cells Is Prevented by Costimulatory Blockade in a Xenograft Model  Annie L. Oh, Dolores Mahmud, Benedetta Nicolini,
HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients  Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,
Induction of T-Cell Responses against Cutaneous T-Cell Lymphomas Ex Vivo by Autologous Dendritic Cells Transfected with Amplified Tumor mRNA  Xiao Ni,
Volume 29, Issue 3, Pages (September 2008)
Down-Regulation of IL-4 Gene Transcription and Control of Th2 Cell Differentiation by a Mechanism Involving NFAT1  Alexander Kiani, João P.B Viola, Andrew.
Volume 25, Issue 10, Pages (October 2017)
Volume 39, Issue 4, Pages (October 2003)
Volume 28, Issue 6, Pages (June 2008)
Stanford L Peng, Andrea J Gerth, Ann M Ranger, Laurie H Glimcher 
Volume 24, Issue 2, Pages (February 2006)
Volume 22, Issue 10, Pages (March 2018)
Andy K. W. Hsu, Beverley M. Kerr, Kathryn L. Jones, Richard B
Volume 120, Issue 2, Pages (February 2001)
The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells  Juha Punnonen, MD, PhD, Hans Yssel, PhD,
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Volume 135, Issue 3, Pages (September 2008)
Arsenic Induces Tumor Necrosis Factor α Release and Tumor Necrosis Factor Receptor 1 Signaling in T Helper Cell Apoptosis  Hsin-Su Yu, Gwo-Shing Chen 
Volume 117, Issue 3, Pages (September 1999)
CTLA-4 Regulates Induction of Anergy In Vivo
Human CD4+ T Lymphocytes with Remarkable Regulatory Functions on Dendritic Cells and Nickel-Specific Th1 Immune Responses  Andrea Cavani, Francesca Nasorri,
Volume 5, Issue 1, Pages (July 1996)
Volume 16, Issue 4, Pages (April 2002)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
Cord Blood Nucleated Cells Induce Delayed T Cell Alloreactivity
Human Langerhans Cells Are More Efficient Than CD14−CD1c+ Dermal Dendritic Cells at Priming Naive CD4+ T Cells  Laetitia Furio, Isabelle Briotet, Alexandra.
Dimethylfumarate Induces Immunosuppression via Glutathione Depletion and Subsequent Induction of Heme Oxygenase 1  Joachim C.U. Lehmann, Joanna J. Listopad,
Machteld M. Tiemessen, Tracey J. Mitchell, Lisa Hendry, Sean J
Volume 57, Issue 2, Pages (October 2000)
Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to Viruses  Weisan Chen, Luis C. Antón, Jack R. Bennink,
Volume 67, Issue 6, Pages (June 2005)
Adoptive transfer of gene-engineered CD4+ helper T cells induces potent primary and secondary tumor rejection by Maria Moeller, Nicole M. Haynes, Michael.
Induction of anergic allergen-specific suppressor T cells using tolerogenic dendritic cells derived from children with allergies to house dust mites 
Volume 29, Issue 3, Pages (September 2008)
Presentation transcript:

Human CD34+ blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade  Mario Arpinati, Carolina Terragna, Gabriella Chirumbolo, Simonetta Rizzi, Benedetta Urbini, Francesca Re, Sante Tura, Michele Baccarani, Damiano Rondelli  Experimental Hematology  Volume 31, Issue 1, Pages 31-38 (January 2003) DOI: 10.1016/S0301-472X(02)01018-4

Figure 1 Anti-CD40L mAb and CTLA4-Ig inhibit T-cell alloreactivity to CD34+ cells. Freshly isolated CD34+ blood cells were irradiated and mixed with 5 × 104 HLA-mismatched MNC at 1:2 S/R ratio in the presence of different doses of anti-CD40L mAb (A, left), or CTLA4-Ig (A, right). Each molecule was used separately, or in combination, in further MLC experiments where T-cell alloreactivity to CD34+ cells in the presence of costimulatory blockade was measured by 3H-thymidine incorporation assay after 6 days of culture (B). Inhibition of allogeneic T-cell response by anti-CD40L mAb plus CTLA4-Ig was greater than by anti-CD40L mAb (p = 0.008), or CTLA4-Ig alone (p = 0.05). Results are given as mean ± SD of four separate experiments. Experimental Hematology 2003 31, 31-38DOI: (10.1016/S0301-472X(02)01018-4)

Figure 2 Induction of CTL responses by CD34+ cells is principally mediated by B7:CD28 signal. After priming allogeneic MNC with irradiated CD34+ blood cells, with or without anti-CD40L mAb and/or CTLA4-Ig, the cytotoxic effect against alloantigen-specific PHA blasts was assessed in a standard 51Cr release assay. CTL generation was greatly reduced by the presence of CTLA4-Ig, whereas little effect was elicited by anti-CD40L mAb. Autologous control effectors always showed less than 10% lytic activity. This result is representative of three separate experiments. Experimental Hematology 2003 31, 31-38DOI: (10.1016/S0301-472X(02)01018-4)

Figure 3 Effect of anti-CD40L mAb and/or CTLA4-Ig added to irradiated CD34+ cells in primary MLC on T-cell response in secondary MLC. Allogeneic MNC were stimulated in primary MLC by HLA-mismatched irradiated CD34+ cells (S/R ratio of 1:2) with or without anti-CD40L mAb and/or CTLA4-Ig. After 6 days the cells were harvested and rested for 2 days. The cells then were restimulated with allogeneic MNC (from the same donor as in primary MLC) in the absence (−IL-2) or in the presence of 50 UI/mL IL-2 (+IL-2). Alloantigen-specific T-cell secondary proliferative response was measured by 3H-thymidine assay after 3 days. Results are given as stimulation index ± SD. Experimental Hematology 2003 31, 31-38DOI: (10.1016/S0301-472X(02)01018-4)

Figure 4 Unresponsiveness induced by CD34+ cell stimulation and costimulatory blockade is antigen specific. Allogeneic MNC were stimulated in primary MLC by HLA-mismatched irradiated CD34+ cells (S/R ratio of 1:2) without (black bars) or with (white bars) anti-CD40L mAb and CTLA4-Ig. After 6 days the cells were harvested and rested for 2 days. The cells then were restimulated with allogeneic MNC from the same donor as in primary MLC (alloantigen) for 3 days or from a third party donor (3rd party) for 6 days or with tetanus toxoid (TT) for 6 days, or with PHA for 3 days. Proliferative response was assessed by 3H-thymidine incorporation assay. Responder cells that had been activated in the presence of costimulatory blockade were unresponsive to the same alloantigen previously presented by CD34+ cells, which showed proliferative responses against third party, or tetanus toxoid antigen, or to PHA, comparable to control cells. Results are given as stimulation index ± SD. Experimental Hematology 2003 31, 31-38DOI: (10.1016/S0301-472X(02)01018-4)

Figure 5 Effect of costimulatory blockade in primary MLC on cytokine production upon alloantigen rechallenge. Allogeneic MNC were stimulated in primary MLC by HLA-mismatched irradiated CD34+ cells (at 1:2 S/R ratio) without (white bars) or with (black bars) anti-CD40L mAb and CTLA4-Ig. After 6 days the cells were harvested and rested for 2 days. The cells then were restimulated with allogeneic MNC from the same donor as in primary MLC for 24 hours. Culture supernatants were collected and IFN-γ, TNFα, IL-2, IL-10, IL-5, and IL-4 were measured by flow cytometry using the CBA kit (Becton-Dickinson). Costimulatory blockade induced suppression of IFN-γ and resulted in an increase of IL-10 production. IL-2 and IL-4 results were always under the limit of detection for this assay, which is 12 pg/mL for all the cytokines. Cytokines production is given as mean ± SD, and results are representative of three separate experiments. Experimental Hematology 2003 31, 31-38DOI: (10.1016/S0301-472X(02)01018-4)

Figure 6 Increased IL-10 expression in anergic responder cells upon alloantigen rechallenge. Allogeneic MNC were stimulated in primary MLC by HLA-mismatched irradiated CD34+ cells (S/R ratio of 1:2) without (white bars) or with (black bars) anti-CD40L mAb and CTLA4-Ig. After 6 days the cells were harvested and rested for 2 days. The cells then were restimulated with allogeneic MNC from the same donor as in primary MLC for 6 hours (left) or 24 hours (right). The cells were collected and quantitative mRNA expression of IFN-γ, IL-2, IL-10, and IL-4 analyzed by real-time PCR (see Methods). As early as 6 hours after antigen rechallenge in the cells that had been activated by CD34+ cells and costimulatory blockade, higher expression of IL-10, reduced expression of IL-2, and no IFN-γ were observed compared to control cultures. Upon prolonging the culture to 24 hours the pattern of cytokine expression was maintained. Results are given as the ratio of ΔΔCt in antigen-stimulated/unstimulated cells. Experimental Hematology 2003 31, 31-38DOI: (10.1016/S0301-472X(02)01018-4)